Eagle Pharmaceuticals Inc (OTCPK:EGRX)
$ 0.5 -0.0102 (-2%) Market Cap: 6.48 Mil Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 60/100

Eagle Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Oct 02, 2019 / 11:45AM GMT
Release Date Price: $56.96 (+0.96%)
Brandon Folkes
Cantor Fitzgerald - Analyst

Good morning, everyone. Thanks very much for coming to the Cantor healthcare conference. So to start events this morning, in the Empire Ballroom we have Eagle Pharmaceuticals. And presenting for Eagle will be CEO, Scott Tarriff. And the CFO, Pete Meyers, is also in attendance.

Thank you, Scott.

Scott Tarriff
Eagle Pharmaceuticals, Inc. - Founder and CEO

Thank you, Brandon. Thank you for joining us today. It's great having you here, so thank you. It's early in the morning. (technical difficulty) All right. I'll just go ahead and chat. Actually, it's really enjoyable that way.

So, look, here's what I'd like to say as we start today: in the almost 14 years since Eagle was founded, we have evolved quite a bit, and the company continues to evolve. And I have to say that we are as excited today, more excited than we've been with our business at any time. And the way I would hope that you would think about us now, when you see what we're working on, is think about us as a small pharmaceutical company. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot